Postacute Sequelae of Sars-CoV-2

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Postacute Sequelae of Sars-CoV-2 trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (3 shown)

Not Yet RecruitingPhase 1

NCT07388550

Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)

Background: SARS-CoV-2 is the virus that causes COVID-19. Some people who recover from an acute COVID-19 infection may continue to have symptoms that persist f…

United States15 participantsStarted 2026-05-13

Treatment: Keytruda

CompletedNot Applicable

NCT05200858

Transcutaneous Electrical Nerve Stimulation (TENS) in Patients With Postacute Sequelae of Sars-CoV-2

The purpose of the pilot study is to examine acceptability and proof of concept effectiveness of a wireless TENS technology to address PASC associated FM. Sampl…

United States30 participantsStarted 2022-03-01

Treatment: TENS - high-dose, TENS - low-dose

CompletedPhase 2

NCT05497089

Temelimab as a Disease Modifying Therapy in Patients With Neuropsychiatric Symptoms in Post-COVID 19 or PASC Syndrome

This study is a Phase 2, 24-week, randomized, prospective, double-blind, multicenter study in patients experiencing neuropsychiatric symptoms and functional imp…

Italy, Spain203 participantsStarted 2022-08-29

Treatment: Temelimab 54mg/kg, Placebo